PRIMA1 and hepatocellular carcinoma: Finally, we show that PRIMA-1 synergizes with cisplatin in mutp53 HCC cells, supporting the premise that PRIMA-1 may enhance the response of a subset of HCC patients undergoing cisplatin therapy.